Insmed (INSM) Common Equity (2010 - 2026)
Insmed (INSM) reported Common Equity of $726.21 million for Q3 2026, down 23.2% from $945.57 million a year earlier and down 4.1% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Insmed posted Common Equity of $738.98 million, up 158.9% from FY2024.
- Common Equity has a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
- By year, Common Equity came in at $285.38 million in FY2024, -$331.92 million in FY2023, $87.95 million in FY2022 (-78.6%) and $410.47 million in FY2021 (+48.8%).
- Five-year quarterly Common Equity spans a low of -$464.81 million in Q1 2024 and a high of $1.25 billion in Q2 2025.
- Year over year, Common Equity gained in three of the last five quarters, with growth averaging 160.6%.
- The high point for year-over-year Common Equity in five years was Q1 2026 (growth of 610.8%); the low point was Q2 2022 (a decline of 91.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $757.49 million (Q2 2026), $704.85 million (Q1 2026) and $738.98 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | 726.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 726.21 Mn |
| Jun 30, 2026 | 757.49 Mn |
| Mar 31, 2026 | 704.85 Mn |
| Dec 31, 2025 | 738.98 Mn |
| Sep 30, 2025 | 945.57 Mn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 99.16 Mn |
| Dec 31, 2024 | 285.38 Mn |
| Sep 30, 2024 | 483.42 Mn |
| Jun 30, 2024 | 38.82 Mn |
| Mar 31, 2024 | -464.81 Mn |
| Dec 31, 2023 | -331.92 Mn |
| Sep 30, 2023 | -289.36 Mn |
| Jun 30, 2023 | -155.75 Mn |
| Mar 31, 2023 | -44.65 Mn |
| Dec 31, 2022 | 87.95 Mn |
| Sep 30, 2022 | -29.96 Mn |
| Jun 30, 2022 | 44.24 Mn |
| Mar 31, 2022 | 119.88 Mn |
| Dec 31, 2021 | 410.47 Mn |
API Access
Insmed Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();